Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: Arimidex
Latest Medical Consensus on Preventing Breast Cancer
Breast cancer is the most common cancer in women worldwide, with the annual incidence estimated to be 1.4 million cases in 2008. Rates are highest in North American, Western Europe andAustralia, but the rates are also increasing in developing countries. … Continue reading
Posted in Breast cancer, Cancer
Tagged anastrozole, Arimidex, Aromasin, arzoxifene, Bisphosphonates, Breast cancer, Cancer prevention, COX-2 inhiitors, Evista, exemestane, Fablyn, Femara, lasofoxifene, letrozole, Metformin, Nolvadex, NSAIDs, raloxifene, retinoids, rexinoids, selective estrogen-receptor modulators, SERMS, tamoxifen
Comments Off on Latest Medical Consensus on Preventing Breast Cancer
Breast and Endometrial Cancer – Causes, Symptoms, Diagnosis, Prognosis and Hormonal Treatment
Breast Cancer Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death in the United States. It is estimated that the lifetime risk of developing breast cancer is one in eight, with … Continue reading
Posted in Breast cancer, Cancer, Endometrial Cancer
Tagged anastrozole, Arimidex, Aromasin, aromatase inhibitors, AstraZeneca, Breast cancer, Causes, Depo-Provera, Diagnosis, Endometrial cancer, estrogen antagonist, estrogen receptor antagonist, exemestane, Fareston, Faslodex, Femara, fulvestrant, Gonadotropin-releasing hormone, goserelin, Her2, Hormonal treatment, letrozole, leuprorelin acetate, mammography, medroxyprogesterone, Megace, megestrol, Nolvadex, progestins, Prognosis, Selective Estrogen Receptors Modulator, SERMS, Symptoms, tamoxifen, toremifene, Viadur, Zoladex
1 Comment
Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
According to a new study published in the Clinical Cancer Research, adding epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) to anastrozole (Arimidex) improved progression-free survival in postmenopausal women with hormone receptor-positive metastatic breast cancer. The study randomized 93 postmenopausal … Continue reading
Posted in Breast cancer, Cancer
Tagged anastrozole, Arimidex, Breast cancer, gefitinib, Iressa, Survival
Comments Off on Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
